Evidence map›Paper›PMID 38206498›Full record

ArticleCancer causes & control : CCC2024

Variation in patterns of second primary malignancies across U.S. race and ethnicity groups: a Surveillance, Epidemiology, and End Results (SEER) analysis.

Valerie McGuire, Daphne Y Lichtensztajn, Li Tao, Juan Yang, Christina A Clarke, Anna H Wu, Lynne Wilkens, Sally L Glaser, Sungshim Lani Park, Iona Cheng

Abstract read
PubMed Publisher
In one paragraph

Article in Cancer causes & control : CCC, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Immigration and Social Factors, Tumor Stage, and Risk of Contralateral Breast Cancer in Asian American and Hispanic Women.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Patterns of Subsequent Cancer Incidence Over Time in Patients with Breast Cancer.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Valerie McGuireDepartment of Epidemiology and Biostatistics, University of California, San Francisco, CA, 94158-2549, USA. valerie.mcguire@ucsf.edu.
Daphne Y LichtensztajnDepartment of Epidemiology and Biostatistics, University of California, San Francisco, CA, 94158-2549, USA.
Li TaoGreater Bay Area Cancer Registry, Cancer Prevention Institute of California, Fremont, CA, USA.
Juan YangDepartment of Epidemiology and Biostatistics, University of California, San Francisco, CA, 94158-2549, USA.
Christina A ClarkeGreater Bay Area Cancer Registry, Cancer Prevention Institute of California, Fremont, CA, USA.
Anna H WuDepartment of Population and Public Health Science, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Lynne WilkensEpidemiology Program, University of Hawaii at Manoa, Honolulu, HI, USA.
Sally L GlaserGreater Bay Area Cancer Registry, Cancer Prevention Institute of California, Fremont, CA, USA.
Sungshim Lani ParkEpidemiology Program, University of Hawaii at Manoa, Honolulu, HI, USA.
Iona ChengDepartment of Epidemiology and Biostatistics, University of California, San Francisco, CA, 94158-2549, USA.
Cancer Prevention Institute of California · USUniversity of California, San Francisco · USUniversity of Hawaiʻi at Mānoa · USUniversity of Southern California · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeOne in six incident cancers in the U.S. is a second primary cancer (SPC). Although primary cancers vary considerably by race and ethnicity, little is known about the population-based occurrence of SPC across these groups.

methodsUsing Surveillance, Epidemiology, and End Results (SEER) 12 data and relative to the general population, we calculated standardized incidence ratios (SIRs) and 95% confidence intervals (CIs) for SPC among 2,457,756 Hispanics, non-Hispanic Asian American/Pacific Islanders (NHAAPI), non-Hispanic black (NHB), and non-Hispanic whites (NHW) cancer survivors aged 45 years or older when diagnosed with a first primary cancer (FPC) from 1992 to 2015.

resultsThe risk of second primary bladder cancer after first primary prostate cancer was higher than expected in Hispanic (SIR = 1.18, 95% CI: 1.01-1.38) and NHAAPI (SIR = 1.41, 95% CI: 1.20-1.65) men than NHB and NHW men. Among women with a primary breast cancer, Hispanic, NHAAPI, and NHB women had a nearly 1.5-fold higher risk of a second primary breast cancer, while NHW women had a 6% lower risk. Among men with prostate cancer whose SPC was diagnosed 2 to <12 months, NHB men were at higher risk for colorectal cancer and Hispanic and NHW men for non-Hodgkin's lymphoma. In the same time frame for breast cancer survivors, Hispanic and NHAAPI women were significantly more likely than NHB and NHW women to be diagnosed with a second primary lung cancer.

conclusionFuture studies of SPC should investigate the role of shared etiologies, stage of diagnosis, treatment, and lifestyle factors after cancer survival across different racial and ethnic populations.

Indexed as

EthnicityNeoplasms, Second PrimarySEER ProgramAgedAged, 80 and overAsian American Native Hawaiian and Pacific IslanderBlack or African AmericanCancer SurvivorsFemaleHispanic or LatinoHumansIncidenceMaleMiddle AgedRacial GroupsRisk FactorsRace and ethnicitySecond primary cancer

Identifiers

PMID38206498
OpenAlexW4390743261

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.